We are live on ! Find out more

737 hedge funds and large institutions have $10.1B invested in Sanofi in 2026 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 300 increasing their positions, 212 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 300 | Existing positions reduced: 212

1% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 102

0.42% less ownership

Funds ownership: 9.08%8.66% (-0.42%)

2% less funds holding

Funds holding: 754737 (-17)

7% less capital invested

Capital invested by funds: $10.8B → $10.1B (-$714M)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

16% less call options, than puts

Call options by funds: $96.6M | Put options by funds: $115M

Holders
737
Holders Change
-17
Holders Change %
-2.25%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.07%
New
103
Increased
300
Reduced
212
Closed
102
Calls
$96.6M
Puts
$115M
Net Calls
-$18.3M
Net Calls Change
+$42.8M

SNY Hedge Fund Activity: Q1 2026 in Review

737 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2026, worth a combined $10.1B — down 6.6% from $10.8B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new SNY positions and 102 closed out — a net gain of 1 holder — while 300 added to existing stakes and 212 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $159M. The largest seller was Dodge & Cox, cutting an estimated $1.26B.

  • 737 institutional investors held Sanofi (SNY) as of Q1 2026, down from 754 in Q4 2025.
  • Funds reported $10.1B of Sanofi stock for Q1 2026, down 6.6% quarter-over-quarter.
  • 103 funds opened new Sanofi positions in Q1 2026 and 102 closed out, a net change of +1 holder.
  • The largest Sanofi buyer in Q1 2026 was Morgan Stanley, an estimated $159M added.
  • The largest Sanofi seller in Q1 2026 was Dodge & Cox, an estimated $1.26B sold.

Based on aggregated 13F filings for Q1 2026.